Global Anti-Peptic Ulcer Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 15-Sep-2022
No. of pages: 107
Inquire Before Buying

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Anti-Peptic Ulcer Drugs market is projected to reach US$ 21220 million by 2028 from an estimated US$ 9979.8 million in 2022, at a CAGR of 13.4% during 2023 and 2028.

Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.

In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Anti-Peptic Ulcer Drugs.

The Anti-Peptic Ulcer Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Anti-Peptic Ulcer Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-Peptic Ulcer Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- AstraZeneca

- Ask-pharm

- Takeda

- Yangtze River Pharm

- Shandong Luoxin

- Huadong Medicine

- Changzhou Siyao

- Beijing Yuekang

- Guangdong Dahua

- Xian Janssen

Product Type Insights

Global markets are presented by Anti-Peptic Ulcer Drugs type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Anti-Peptic Ulcer Drugs are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Anti-Peptic Ulcer Drugs Segment by Type

- Proton Pump Inhibitors (PPIs)

- Potassium-Competitive Acid Blockers (P-CAB)

- Antacids

- H2 Antagonists

- Ulcer Protective Drugs

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Anti-Peptic Ulcer Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Anti-Peptic Ulcer Drugs market.

Anti-Peptic Ulcer Drugs Segment by Application

- Gastritis

- Gastric Ulcers

- Duodenal Ulcers

- Gastroesophageal Reflux Disease (GERD)

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Anti-Peptic Ulcer Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Peptic Ulcer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Anti-Peptic Ulcer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Anti-Peptic Ulcer Drugs industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Peptic Ulcer Drugs.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Anti-Peptic Ulcer Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Anti-Peptic Ulcer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Ulcer Protective Drugs
1.3 Market by Application
1.3.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Peptic Ulcer Drugs Market Size Estimates and Forecasts
2.2 Anti-Peptic Ulcer Drugs Market Size by Region: 2022 Versus 2028
2.2.1 Global Anti-Peptic Ulcer Drugs Revenue by Region: 2017-2022
2.2.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Region (2023-2028)
2.2.3 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2017-2028)
3 Global Anti-Peptic Ulcer Drugs by Company
3.1 Global Anti-Peptic Ulcer Drugs Revenue by Company (2017-2022)
3.2 Global Anti-Peptic Ulcer Drugs Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Anti-Peptic Ulcer Drugs Companies around the World: Ranking by Revenue
3.3.2 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Anti-Peptic Ulcer Drugs Companies Headquarters & Product Type
3.4.1 Anti-Peptic Ulcer Drugs Companies Headquarters
3.4.2 Global Anti-Peptic Ulcer Drugs Companies Product & Service
3.4.3 Date of International Companies Enter into Anti-Peptic Ulcer Drugs Market
3.5 Global Anti-Peptic Ulcer Drugs Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 AstraZeneca
4.1.1 AstraZeneca Corporation Information
4.1.2 AstraZeneca Description, Business Overview
4.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Products Offered
4.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.1.5 AstraZeneca Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.1.6 AstraZeneca Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.1.7 AstraZeneca Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.1.8 AstraZeneca Recent Developments
4.2 Ask-pharm
4.2.1 Ask-pharm Corporation Information
4.2.2 Ask-pharm Description, Business Overview
4.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Products Offered
4.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.2.5 Ask-pharm Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.2.6 Ask-pharm Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.2.7 Ask-pharm Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.2.8 Ask-pharm Recent Developments
4.3 Takeda
4.3.1 Takeda Corporation Information
4.3.2 Takeda Description, Business Overview
4.3.3 Takeda Anti-Peptic Ulcer Drugs Products Offered
4.3.4 Takeda Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.3.5 Takeda Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.3.6 Takeda Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.3.7 Takeda Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.3.8 Takeda Recent Developments
4.4 Yangtze River Pharm
4.4.1 Yangtze River Pharm Corporation Information
4.4.2 Yangtze River Pharm Description, Business Overview
4.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Products Offered
4.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.4.5 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.4.6 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.4.7 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.4.8 Yangtze River Pharm Recent Developments
4.5 Shandong Luoxin
4.5.1 Shandong Luoxin Corporation Information
4.5.2 Shandong Luoxin Description, Business Overview
4.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Products Offered
4.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.5.5 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.5.6 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.5.7 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.5.8 Shandong Luoxin Recent Developments
4.6 Huadong Medicine
4.6.1 Huadong Medicine Corporation Information
4.6.2 Huadong Medicine Description, Business Overview
4.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Products Offered
4.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.6.5 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.6.6 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.6.7 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.6.8 Huadong Medicine Recent Development
4.7 Changzhou Siyao
4.7.1 Changzhou Siyao Corporation Information
4.7.2 Changzhou Siyao Description, Business Overview
4.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Products Offered
4.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.7.5 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.7.6 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.7.7 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.7.8 Changzhou Siyao Recent Development
4.8 Beijing Yuekang
4.8.1 Beijing Yuekang Corporation Information
4.8.2 Beijing Yuekang Description, Business Overview
4.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Products Offered
4.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.8.5 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.8.6 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.8.7 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.8.8 Beijing Yuekang Recent Development
4.9 Guangdong Dahua
4.9.1 Guangdong Dahua Corporation Information
4.9.2 Guangdong Dahua Description, Business Overview
4.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Products Offered
4.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.9.5 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.9.6 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.9.7 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.9.8 Guangdong Dahua Recent Development
4.10 Xian Janssen
4.10.1 Xian Janssen Corporation Information
4.10.2 Xian Janssen Description, Business Overview
4.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Products Offered
4.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2017-2022)
4.10.5 Xian Janssen Anti-Peptic Ulcer Drugs Revenue by Product in 2021
4.10.6 Xian Janssen Anti-Peptic Ulcer Drugs Revenue by Application in 2021
4.10.7 Xian Janssen Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2021
4.10.8 Xian Janssen Recent Development
5 Breakdown Data by Type
5.1 Global Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022)
5.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Type (2023-2028)
5.3 Anti-Peptic Ulcer Drugs Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022)
6.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Application (2023-2028)
6.3 Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Anti-Peptic Ulcer Drugs Market Size YoY Growth 2017-2028
7.2 North America Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2017-2028)
7.3 North America Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022)
7.4 North America Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Anti-Peptic Ulcer Drugs Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022)
8.4 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022)
9 Europe
9.1 Europe Anti-Peptic Ulcer Drugs Market Size YoY Growth 2017-2028
9.2 Europe Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2017-2028)
9.3 Europe Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022)
9.4 Europe Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Anti-Peptic Ulcer Drugs Market Size YoY Growth 2017-2028
10.2 Latin America Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2017-2028)
10.3 Latin America Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022)
10.4 Latin America Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Anti-Peptic Ulcer Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022)
11.4 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Anti-Peptic Ulcer Drugs Supply Chain Analysis
12.2 Anti-Peptic Ulcer Drugs Key Raw Materials and Upstream Suppliers
12.3 Anti-Peptic Ulcer Drugs Clients Analysis
12.4 Anti-Peptic Ulcer Drugs Sales Channel and Sales Model Analysis
12.4.1 Anti-Peptic Ulcer Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Anti-Peptic Ulcer Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Anti-Peptic Ulcer Drugs Distributors
13 Market Dynamics
13.1 Anti-Peptic Ulcer Drugs Industry Trends
13.2 Anti-Peptic Ulcer Drugs Market Drivers
13.3 Anti-Peptic Ulcer Drugs Market Challenges
13.4 Anti-Peptic Ulcer Drugs Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Proton Pump Inhibitors (PPIs)
Table 3. Major Companies of Potassium-Competitive Acid Blockers (P-CAB)
Table 4. Major Companies of Antacids
Table 5. Major Companies of H2 Antagonists
Table 6. Major Companies of Ulcer Protective Drugs
Table 7. Global Anti-Peptic Ulcer Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Anti-Peptic Ulcer Drugs Market Size by Region (US$ Million): 2022 VS 2028
Table 9. Global Anti-Peptic Ulcer Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Anti-Peptic Ulcer Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Anti-Peptic Ulcer Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 12. Anti-Peptic Ulcer Drugs Revenue Share by Company (2017-2022)
Table 13. Ranking of Global Top Anti-Peptic Ulcer Drugs Players by Revenue (US$ Million) in 2021
Table 14. Global Anti-Peptic Ulcer Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 15. Global Anti-Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2021)
Table 16. Global Anti-Peptic Ulcer Drugs Companies Headquarters
Table 17. Global Anti-Peptic Ulcer Drugs Companies Product & Service
Table 18. Date of International Companies Enter into Anti-Peptic Ulcer Drugs Market
Table 19. Global Anti-Peptic Ulcer Drugs Mergers & Acquisitions, Expansion Plans
Table 20. AstraZeneca Corporation Information
Table 21. AstraZeneca Description and Business Overview
Table 22. AstraZeneca Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 23. AstraZeneca Anti-Peptic Ulcer Drugs Product
Table 24. AstraZeneca Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 25. AstraZeneca Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 26. AstraZeneca Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 27. AstraZeneca Recent Development
Table 28. Ask-pharm Corporation Information
Table 29. Ask-pharm Description and Business Overview
Table 30. Ask-pharm Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 31. Ask-pharm Anti-Peptic Ulcer Drugs Product
Table 32. Ask-pharm Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 33. Ask-pharm Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 34. Ask-pharm Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 35. Ask-pharm Recent Development
Table 36. Takeda Corporation Information
Table 37. Takeda Description and Business Overview
Table 38. Takeda Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 39. Takeda Anti-Peptic Ulcer Drugs Product
Table 40. Takeda Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 41. Takeda Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 42. Takeda Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 43. Takeda Recent Development
Table 44. Yangtze River Pharm Corporation Information
Table 45. Yangtze River Pharm Description and Business Overview
Table 46. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 47. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
Table 48. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 49. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 50. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 51. Yangtze River Pharm Recent Development
Table 52. Shandong Luoxin Corporation Information
Table 53. Shandong Luoxin Description and Business Overview
Table 54. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 55. Shandong Luoxin Anti-Peptic Ulcer Drugs Product
Table 56. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 57. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 58. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 59. Shandong Luoxin Recent Development
Table 60. Huadong Medicine Corporation Information
Table 61. Huadong Medicine Description and Business Overview
Table 62. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 63. Huadong Medicine Anti-Peptic Ulcer Drugs Product
Table 64. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 65. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 66. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 67. Changzhou Siyao Corporation Information
Table 68. Changzhou Siyao Description and Business Overview
Table 69. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 70. Changzhou Siyao Anti-Peptic Ulcer Drugs Product
Table 71. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 72. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 73. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 74. Beijing Yuekang Corporation Information
Table 75. Beijing Yuekang Description and Business Overview
Table 76. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 77. Beijing Yuekang Anti-Peptic Ulcer Drugs Product
Table 78. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 79. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 80. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 81. Guangdong Dahua Corporation Information
Table 82. Guangdong Dahua Description and Business Overview
Table 83. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 84. Guangdong Dahua Anti-Peptic Ulcer Drugs Product
Table 85. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 86. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 87. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 88. Xian Janssen Corporation Information
Table 89. Xian Janssen Description and Business Overview
Table 90. Xian Janssen Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 91. Xian Janssen Anti-Peptic Ulcer Drugs Product
Table 92. Xian Janssen Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2021
Table 93. Xian Janssen Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2021
Table 94. Xian Janssen Anti-Peptic Ulcer Drugs Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2021
Table 95. Global Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Global Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 97. Global Anti-Peptic Ulcer Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 98. North America Anti-Peptic Ulcer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 99. North America Anti-Peptic Ulcer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 100. North America Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 101. North America Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Region (2017-2028) & (US$ Million)
Table 103. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 104. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 105. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 106. Europe Anti-Peptic Ulcer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 107. Europe Anti-Peptic Ulcer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 108. Europe Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 109. Europe Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Anti-Peptic Ulcer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 111. Latin America Anti-Peptic Ulcer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 112. Latin America Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 113. Latin America Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 114. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 115. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 118. Anti-Peptic Ulcer Drugs Key Raw Materials, Industry Status and Trend
Table 119. Anti-Peptic Ulcer Drugs Key Raw Materials and Upstream Suppliers
Table 120. Anti-Peptic Ulcer Drugs Clients Status and Trend
Table 121. Anti-Peptic Ulcer Drugs Typical Clients
Table 122. Anti-Peptic Ulcer Drugs Distributors
Table 123. Anti-Peptic Ulcer Drugs Market Trends
Table 124. Anti-Peptic Ulcer Drugs Market Drivers
Table 125. Anti-Peptic Ulcer Drugs Market Challenges
Table 126. Anti-Peptic Ulcer Drugs Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Peptic Ulcer Drugs Product Picture
Figure 2. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type in 2021 & 2028
Figure 3. Proton Pump Inhibitors (PPIs) Product Picture
Figure 4. Potassium-Competitive Acid Blockers (P-CAB) Product Picture
Figure 5. Antacids Product Picture
Figure 6. H2 Antagonists Product Picture
Figure 7. Ulcer Protective Drugs Product Picture
Figure 8. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application in 2021 & 2028
Figure 9. Gastritis
Figure 10. Gastric Ulcers
Figure 11. Duodenal Ulcers
Figure 12. Gastroesophageal Reflux Disease (GERD)
Figure 13. Anti-Peptic Ulcer Drugs Report Years Considered
Figure 14. Global Anti-Peptic Ulcer Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Anti-Peptic Ulcer Drugs Market Size 2017-2028 (US$ Million)
Figure 16. Global Anti-Peptic Ulcer Drugs Market Size Market Share by Region: 2022 Versus 2028
Figure 17. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2017-2028)
Figure 18. Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Anti-Peptic Ulcer Drugs Revenue Market Share Forecast by Type (2017-2028)
Figure 20. Global Anti-Peptic Ulcer Drugs Revenue Market Share Forecast by Application (2017-2028)
Figure 21. North America Anti-Peptic Ulcer Drugs Revenue 2017-2028 (US$ Million)
Figure 22. North America Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2017-2022)
Figure 23. North America Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2017-2022)
Figure 24. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue 2017-2028 (US$ Million)
Figure 25. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2017-2028)
Figure 26. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2017-2022)
Figure 27. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2017-2022)
Figure 28. Europe Anti-Peptic Ulcer Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 29. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Country (2017-2028)
Figure 30. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2017-2022)
Figure 31. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2017-2022)
Figure 32. Latin America Anti-Peptic Ulcer Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 33. Latin America Anti-Peptic Ulcer Drugs Revenue Market Share by Country (2017-2022)
Figure 34. Latin America Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2017-2022)
Figure 35. Latin America Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2017-2022)
Figure 36. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 37. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Country (2017-2028)
Figure 38. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2017-2022)
Figure 39. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2017-2022)
Figure 40. Anti-Peptic Ulcer Drugs Supply Chain (Upstream and Downstream Market)
Figure 41. Global Production Market Share of Anti-Peptic Ulcer Drugs Raw Materials by Region in 2021
Figure 42. Anti-Peptic Ulcer Drugs Distribution Channels
Figure 43. Global Anti-Peptic Ulcer Drugs Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 44. Global Anti-Peptic Ulcer Drugs Percentage 2017-2028: Online Sales VS Offline Sales
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs